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Background: The MK1 strain, a novel bacterial isolate from 
soft-rotten tissue of the Neungee mushroom, produces copi-
ous amounts of exopolysaccharide (EPS) in a dextrose mini-
mal medium. This study examined the molecular character-
istics and immunomodulatory activity of MK1 EPS. Methods: 
The EPS in the culture supernatant was purified by cold etha-
nol precipitation, and characterized by SDS- PAGE/silver 
staining and Bio-HPLC. The immunomodulatory activities of 
the EPS were examined using the mouse monocytic cell line, 
RAW 264.7 cells. Results: The molecular weights of the puri-
fied EPS were rather heterogeneous, ranging from 10.6 to 55 
kDa. The EPS was composed of glucose, rhamnose, man-
nose, galactose, and glucosamine at an approximate molar 
ratio of 1.00：0.8：0.71：0.29：0.21. EPS activated the 
RAW cells to produce cytokines, such as TNF-α  and IL-1β, 
and nitric oxide (NO). EPS also induced the expression of 
co-stimulatory molecules, such as B7-1, B7-2 and ICAM-1, 
and increased the phagocytic activity. The macrophage-acti-
vating activity of EPS was not due to endotoxin con-
tamination because the treatment of EPS with polymyin B 
did not reduce the macrophage-activating activity. Conclu-
sion: The EPS produced from the MK1 strain exerts macro-
phage-activating activity.
[Immune Network 2010;10(6):230-238]
INTRODUCTION
Microbial  exopolysaccharides  (EPS)  are  a  polycarbohydrate 
produced and excreted by microorganisms. There are a vari-
ous types of EPS, either homopolysacharides (e.g. cellulose, 
dextran,  mutan, alternant, pullulan, levan and curdlan) and 
heteropolysaccharides  (e.g.  gellan  and  xanthan)  depending 
on the types of repeating subunit (1). Microbial EPSs are ei-
ther capsular polysaccharide bound covalently to the cell sur-
face or slime polysaccharides bound loosely to the cell sur-
face (2). Microbial EPSs play a number of indispensable roles 
in self-protection against harsh environments, such as osmotic 
stress,  desiccation,  UV  radiation,  antimicrobial  substances, 
toxic compounds, and bacteriophage attack (3). In addition, 
microbial EPSs allow the cells to adhere other bacteria, animal 
and plant tissues or inert surfaces, thereby forming biofilms 
(4). Owing to the properties of EPSs, such as water retention, 
film-forming,  texture-enhancing,  thickening,  water  binding, 
gelling, and suspending, various microbial EPSs are expected 
to have immense value in detergents, adhesives, heavy metal 
removal, microbial enhanced oil recovery, wastewater treat-
ment, cosmetics, pharmaceuticals, brewing, food etc. (5). For 
example, Enterobacter cloaceae EPS showing good viscosity, 
even at high temperatures, makes it a good candidate for mi-
crobial  enhanced  oil  recovery  (6).  Gelrite  obtained  from 
Pseudomonas spp. is a new gelling polysaccharide with good 
thermal stability and clarity (7). Xanthan gum produced by 
Xanthomonas campestris has a wide range of applications as 
a thickening and stabilizing agent, particularly in the food in-
dustry, cosmetics, paper milling, textiles, and pharmaceutical Immunomodulatory Activity of Exopolysaccharide
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sector as well as in enhanced oil recovery (8). In addition, 
cell-bound EPS produced by marine bacterium, Zooglea sp., 
was reported to adsorb metal ions, such as chromium, lead, 
and iron in solution (9). In addition, the great value of micro-
bial EPSs would be associated with their various physiological 
activities, such as anti-tumor, anti-viral, anti-inflammation, in-
ducer of interferon production, platelet aggregation inhibition, 
and  colony  stimulating  factor.  For  example,  the  EPSs  pro-
duced by either marine Vibrio or Pseudomonas sp. have anti-
tumor,  antiviral,  and  immunostimulating  activities  (10,11). 
EPS produced by Bifidobacterium longum promotes its colo-
nization on the inner surface of the intestine (12,13) and has 
a  strong  anti-mutagenesis  effect  (14).  EPS  produced  by 
Bacillus licheniformis has antiviral and immunoregulatory ac-
tivities (15). EPS produced by Lactococcus lactis sp. cremoris 
KVS20 exhibits bioactivity, such as lymphocyte mitogenicity 
(16-19), macrophage cytostaticity (20), and cytokine (IFN-γ 
and IL-1β) production in macrophages (21). The MK1 strain, 
a bacterial isolate originated from the soft-rotten tissue of the 
Neungee gill, appears to be a novel bacterium (22,23). The 
m o s t  p e c u l i a r  f e a t u r e  o f  t h e  h e t e r o t r o p h i c  M K 1  s t r a i n  p r o -
duces copious amounts of EPS in a dextrose medium (24).
    In this study, EPS was purified and characterized by SDS- 
PAGE/silver  staining  and  Bio-HPLC.  The  purified  EPS  ex-
hibited immunomodulatory activity on the mouse monocytic 
cell  line.
MATERIALS AND METHODS
Reagents
Carbon sources consumed in minimal salt medium and chem-
icals, such as acetic acid, formaldehyde, sodium thiosulfate, 
silver nitrate, and sodium carbonate, used in the silver stain-
ing  of  EPSs  were  purchased  from  Sigma-Aldrich  Inc.  (St. 
Louis, MO, USA). The size marker kit used to determine the 
total EPS molecular weight was obtained from Fermentas Inc. 
(Burlington, Canada). Ethanol for EPS purification and sulfu-
ric acid needed to determine the glucose equivalent EPS were 
supplied  by  Merck  Ltd.  (Bangkok,  Thailand).  Alcian  blue 
8GX for the quantitation of the acidic sugar in EPS was ac-
q u i r e d  f r o m  A l d r i c h  C h e m i c a l  C o .  ( M i l w a u k e e ,  W I ,  U S A ) .
Cultivation of MK1 strain for EPS production
Ten ml of the MK1 cells grown overnight in a Luria-Bertani 
medium (LB, 1.0% tryptone, 0.5% yeast extract, and 0.5% so-
dium chloride) were inoculated into a 500 ml of basal mini-
mal glucose medium and incubated for 3 days at 30
oC with 
continuous shaking at 150 rpm. The basal minimal glucose 
medium (g/L) was composed of glucose 20.0, Na2HPO4 4.8, 
KH2PO4 4 . 4 ,  ( N H 4)2SO4 1 . 0 ,  M g S O 4·7H2O  0.5,  CaCl2  0.05, 
and FeCl3 0.005. The initial pH of the minimal salt medium 
w a s  a d j u s t e d  t o  p H  7 . 0  b y  a d d i n g  N a 2HPO4  and  KH2PO4. 
Bacterial  growth  was  monitored  by  determining  the  optical 
density  at  600  nm  (DU-65  Spectrophotometer,  Beckman, 
Fullerton,  CA,  USA).
Purification of MK1 exopolysaccharides (EPS)
The supernatant containing EPS was obtained from the MK1 
cell culture by centrifugation (SUPRA 22K, Hanil, Korea) at 
6,520×g for 20 min at 4
oC. The EPS in the supernatant was 
precipitated with three volumes of absolute cold ethanol fol-
lowed  by  incubation  at  4
oC  for  24  hr.  The  ethanol  pre-
cipitated  EPS  was  collected  by  centrifugation  for  15  min  at 
4,520×g, at 4
oC, and the EPS precipitate was suspended in 
2 ml of D-H2O. The EPS was washed three times with cold 
ethanol  and  freeze-dried  (Ilsin
Ⓡ La b. ,  K or ea ) a t −50
oC for 
2 days (25). This freeze-dried EPS was used for the morpho-
logical observations by optical microscopy and scanning elec-
tron  microscopy  (SEM,  S-2500C,  Hitachi,  Japan).  The  dried 
EPS was adjusted with D-H2O to a final volume of 5 ml and 
dialyzed (M.W. cut off 1,000 Da) against 36 L of D-H2O for 
3 days at 4
oC with four changes per day. The EPS in the dia-
lyzed preparation was recovered by cold ethanol precipitation 
and  freeze-drying,  as  described  above.  The  dried  EPS  was 
used for the EPS quantitation, sugar composition analysis, etc.
EPS quantitation
To  express  the  quantity  of  EPS,  both  amounts  of  glucose 
(glucose-equivalent EPS) and acidic sugar (acidic sugar equiv-
alent EPS) were assayed using the phenol-sulfuric acid meth-
od (26,27) and alcian blue binding (25,28), respectively. The 
glucose-equivalent  EPS  was  determined  using  the  standard 
curve constructed with different glucose concentrations (100, 
200,  300,  400,  500μg/ml).  Alcian  blue  (a  cationic  copper 
phthalocyanine  dye)  binds  to  the  anionic  carboxyl  and 
half-ester sulfate groups of acidic EPS to form an insoluble 
precipitate. The intensity of the blue color of the supernatant 
is inversely proportional to the amount of acidic EPS in the 
reaction mixture. Xanthan gum, the reference material need-
ed to assay the acidic sugar quantitation in EPS, was dissolved 
in D-H2O to 0.5 mg/ml by stirring with mild heating for 30 
min  and  then  stored  at  4
oC.  Using  a  standard  curve  con-Immunomodulatory Activity of Exopolysaccharide
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structed with different xanthan gum concentrations (50, 100, 
150, 200μg/ml), the Y-axis on the standard curve was calcu-
lated  by  subtracting  the  OD600  for  each  xanthan  concen-
tration from a blank. The quantity of acidic sugar in EPS was 
estimated  from  the  standard  curve.  All  analyses  were  per-
formed  in  triplicate.
Resolution of EPS by SDS-PAGE
The freeze-dried EPS was resolved by SDS-polyacrylamide gel 
electrophoresis (29). EPS was dissolved in a buffer containing 
2% SDS, 25% glycerol, 60 mM Tris-HCl (pH 6.8), 14.4 mM 
2-mercaptoethanol, and 0.1% bromophenol blue to a concen-
tration  of  1%  (w/v),  and  heated  to  100
oC  for  15  min. 
SDS-PAGE were carried out on 0.1% SDS-15% polyacrylamide 
gel  (100×80×0.15  mm)  in  the  electrophoresis  buffer  (pH 
8.8) containing 25 mM Tris, 192 mM glycine, and 0.1% SDS. 
The details to visualize EPS on the gel by silver staining can 
be found in reference (30). The molecular weights were esti-
mated using the Rf values of the EPS bands from a standard 
curve  constructed  with  the  Rf  values  (the  relative  mobility) 
of the protein size makers, which were plotted on a semi-log-
arithmic graph as a function of the protein molecular weights 
(31).
Analysis of MK1 EPS composition
The sugar composition was analyzed by Bio-liquid chroma-
tography at the Carbohydrate Bioproduct Research Center of 
Sejong University (Seoul, Korea). Twenty μg of the freeze- 
dried EPS was hydrolyzed at 100
oC for 4 hr with 2 M trifluoro-
acetic  acid  in  sealed  test  tubes.  The  EPS-acid  hydrolysates 
w e r e  a n a l y z e d  o n  a  C a r b o P a c T M  P A 1  c o l u m n  w i t h  a  
HPAEC-PAD system (Dionex, Sunnyvale, CA, USA). The col-
umn was eluted at a flow rate of 1 ml/min with 18 mM NaOH 
(for  neutral  and  amino  sugar  detection)  and  100  mM 
N aOH/150 mM N aOAC (for acidic sugar detection), respec-
tively.
Cell culture
The RAW 264.7 cells were cultured in Dulbecco’s modified 
Eagle's  medium  (Hyclone  Laboratories  Inc.,  Logan,  Utah, 
USA) supplemented with 10% heat-inactivated fetal bovine se-
rum (Hyclone) 100 U/ml penicillin and 100μg/ml streptomy-
cin  (Hyclone),  and  50μM  2-mercaptoethanol  (SIGMA,  St. 
L o u i s ,  M O ,  U S A )  a t  3 7
oC  in  an  atmosphere  containing  5% 
CO2.
Proliferation assay
The RAW cells were cultured in the presence of different EPS 
concentrations (48.32μg glucose-equivalent EPS/mg EPS, 9.0
μg acidic sugar equivalent EPS/mg EPS) in a 96-well micro-
titer plate (2×10
4 cells/well). DNA synthesis was measured 
by the level of [
3H]-thymidine (2 Ci/mmol, PerkinElmer, Shel-
ton, CT, USA) incorporation at a concentration of 0.5μCi/well 
for the final 6 hr of the 2 day culture period. The cells were 
harvested onto glass fiber filter paper using an automated cell 
harvester  (Inotech,  Dottikon,  Switzerland).  The  filters  were 
washed, dried and then counted in a microbeta liquid scintil-
lation  counter  (Wallac,  Turku,  Finland).
Cytokine production
The RAW cells were cultured in the presence of different EPS 
concentrations in a 24-well microtiter plate (5×10
5 cells/well) 
in a total volume of 1 ml. After 48 hr incubation, the culture 
supernatants were collected, and the quantities of IL-1β and 
TNF-α were measured using commercial immunoassay kits 
(BD Biosciences, San Diego, CA, USA) according to the man-
ufacturer’s  instruction.
Nitric oxide production
The RAW cells were cultured in the presence of different con-
centrations  of  EPS  in  a  24-well  microtiter  plate  (5×10
5 
cells/well) in a total volume of 1 ml. After 48 hr stimulation, 
50μl of the cell-free supernatants were collected, incubated 
with  an  equal  volume  of  Griess  reagent  (1%  sulfanilamide, 
0.1%  naphthylenediamine  dihydrochloride,  5%  H3PO4)  at 
room temperature for 5 min, and the absorbance at 550 nm 
w a s  d e t e r m i n e d  u s i n g  a  V E R S A max  (Molecular  Devices  Inc., 
CA, USA) microplate reader. The NO2
− concentration was de-
termined from the least squares linear regression analysis of 
a  sodium  nitrite  standard  curve.
Flow cytometry
The cells were stained with the monoclonal antibodies recog-
nizing  murine cell  surface  markers,  as  previously  described 
(32). Phenotypic analysis of the macrophages was performed 
on  a FACSCanto  II (Becton-Dickinson, San Jose,  CA, USA), 
and the data was analyzed using FlowJo software. The mono-
clonal antibodies, anti-CD40 (clone 3/23), anti- ICAM-1 (clone 
3E2), anti-I-A
b (clone AF6-120.1), anti-B7-1 (clone 16-10A1), 
anti-B7-2 (clone GL1), and isotype-matched control antibodies 
were purchased from Pharmingen (San Diego, CA, USA). The 
dead cells were gated out by their low forward angle light Immunomodulatory Activity of Exopolysaccharide
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Figure 1. Photographs of MK1 ex-
opolysaccharide. (A) Colony mor-
phology of MK1 on potato dextrose 
agar, (B) Purified EPS (freeze-dried 
powder), (C) optical microscopy 
view of EPS (40×), (D) SEM view 
(6,000×).
Figure 2. EPS resolved by SDS-PAGE. Resolution of the protein 
markers (5μl) and EPS (150μg) on 0.1% SDS-15% polyacrylamide 
gel.
scatter intensity. In most analyses, 10,000 cells were scored.
Phagocytic activity
The  RAW  cells  were  cultured  in  6-well  plates  (2×10
6 
cells/well) in the presence or absence of EPS for 2 days, and 
then added with biodegradable microspheres (average diame-
ter,  300  nm)  containing  both  ovalbumin  (OVA)  and  fluo-
rescein  isothiocyanate  (FITC).  The  cells  were  incubated  for 
2 hr and washed with pre-warmed PBS to remove the un-
phagocytozed  microspheres.  The  cells  were  then  harvested 
by pipetting after cooling on ice for 20 min, fixed in 1% paraf-
ormaldehyde in PBS, and analyzed by flow cytometry on a 
FACSCanto II. Microspheres containing both OVA and FITC 
were  prepared  using  a  solvent-evaporation  method  (33). 
Briefly, OVA was dissolved in 3% polyvinyl alcohol (final, 4 
mg/ml), and poly (l-lactic acid) (PLG, final, 5%), and FITC 
(final, 5 mg/ml) were dissolved in a mixture of acetone and 
ethanol (9：1). These two solutions, 150 ml of OVA solution 
and 30 ml of the PLG solution, were mixed slowly and emul-
sified by continuous stirring overnight at room temperature. 
The hardened microspheres were collected by centrifugation 
a t  3 0 0 × g ,  a n d  w a s h e d  t w i c e  w i t h  P B S .
Removal of endotoxin
The possible contaminants of endotoxin contained in the EPS 
were  removed  using  Affi-Prep  Polymyxin  Matrix  (BIO-RAD, 
H e r c u l e s ,  C A ,  U S A ) .  B r i e f l y ,  1  m l  o f  A f f i - P r e p  P o l y m y x i n  
Matrix was packed in a Bio-spin column (BIO-RAD), centri-
fuged for 2 min at 200×g, and then 0.5 ml of the EPS (200μ
g/ml) was added. After incubating overnight at 4
oC, the efflu-
ent was recovered from the column by centrifugation under 
the  same  conditions.
RESULTS
Composition and characterization of MK1 EPS
The EPS obtained from the MK1 strain grown in a minimal 
glucose  medium  was  observed  by  optical  microscopy  and 
SEM (Fig. 1). The freeze-dried EPS was a white powder and 
was readily soluble in water. The molecular weights of the 
purified  EPS  were  rather  heterogeneous,  ranging  from  10.6 
to 55 kDa, when it was resolved by SDS-PAGE/silver staining 
(Fig. 2). Complete hydrolysis of the EPS with 2 M trifluoro-
acetic acid followed by monosaccharide composition analysis 
showed that this EPS was a heteropolysaccharide composed 
of glucose, rhamnose, mannose, galactose, glucosamine in an 
approximate  molar  ratio  of  1.00：0.8：0.71：0.29：0.21 
with  a  trace  amount  of  fucose,  fructose,  and  galacturonic 
acid,  as  shown  in  Fig.  3.
Effects of MK1 EPS on the growth of RAW cells
To examine the immnuomodulatory activity of EPS, EPS was 
added to the cultures of RAW cells, and the growth inhibitory 
activity was observed 2 days later. The growth inhibitory ac-Immunomodulatory Activity of Exopolysaccharide
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Figure 3. Sugar profile of EPS by 
Bio-LC. Twenty μg of the freeze- 
dried EPS was hydrolyzed at 100
oC 
for 4 hr with 2 M trifluoroacetic acid
in sealed test tubes. The EPS-acid 
hydrolysates were analyzed on a 
CarboPacTM PA1 column with a 
HPAEC-PAD system. (A) The profile 
of neutral and amino sugar. (B) 
Profile of acidic sugar.
Figure 4. Growth inhibition of RAW cells stimulated with MK1. EPS
was treated with a polymyxin B-affinity column to remove any 
possible endotoxin contamination. RAW cells were cultured in the 
presence of different MK1 EPS concentrations (0.8, 4, 20 and 100μ
g/ml) for 2 days, and DNA synthesis was measured by [
3H]-thymidine
incorporation for the final 6 hr of the 2 day culture period. The CPM
values of the untreated RAW cells served as control values in the 
calculation of % inhibition.
tivity of the EPS on RAW cells was documented further by 
the [
3H]-thymidine uptake for the final 6 hr of the 2 day cul-
ture  period.  As  shown  in  Fig.  4,  EPS  inhibited  the  growth 
of RAW cells in a dose dependent manner. The growth in-
hibitory activity of EPS reached 90% at 100μg/ml. EPS was 
treated with polymyxin B, which is a specific inhibitor of pol-
ysaccharide, to ensure that the effects of the EPS were not 
due to endotoxin contamination. Passage of the EPS solution 
(200μg/ml) through the polymyxin B-affinity column did not 
reduce the growth inhibitory activity. The growth inhibitory 
activity  of  EPS  was  not  due  to  direct  cytotoxicity.
Effects of MK1 EPS on the expression of surface 
molecules
The increased expression of co-stimulatory molecules can be 
a marker of macrophage activation. Therefore, the effects of 
EPS on the expression of co-stimulatory molecules on RAW 
c e l l s ,  w h i c h  w e r e  i n v o l v e d  i n  T  c e l l  a c t i v a t i o n ,  w e r e  a l s o  
examined.  As  shown  in  Fig.  5,  100μg / m l  E P S  i n c r e a s e d  
slightly the expression of B7-1, B7-2 and ICAM-1. This dem-
o n s t r a t e s  t h a t  E P S  i n d u c e s  t h e  f u r t h e r  d i f f e r e n t i a t i o n  o f  
macrophages.
Effects of MK1 EPS on the production of cytokines 
and nitric oxide
Cytokine  and  nitric  oxide  production  is  a  parameter  of  the 
functional  activation  of  macrophages.  To  determine  if  the 
EPS-activated RAW cells produced cytokines and nitric oxide, 
the culture supernatants were collected at 48 hr and the quan-
tity of TNF-α, IL-1β and nitric oxide were measured. The 
stimulatory activity of EPS on macrophages was demonstrated 
further by the dose-dependent increase in TNF-α production 
(Fig. 6A), IL-1β production (Fig. 6B) and nitric oxide release 
(Fig. 6C) by RAW cells stimulated with EPS. As shown in a 
representative result in Fig. 6, the incubation of EPS with a 
polymyxin  B-  affinity  column  did  not  reduce  the  macro-
phage-activating  activity.
Effects of MK1 EPS on phagocytic activity
The phagocytic activity of the EPS-activated RAW cells was 
examined using the microspheres containing fluorescein iso-
thiocyanate  (FITC). One  of  the most  distinguishing features 
of macrophage activation would be the increase in phagocytic 
activity. RAW cells were cultured in the presence of EPS (100
μg/ml) for 2 days, and added with the microspheres contain-Immunomodulatory Activity of Exopolysaccharide
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Figure 5. Phenotypic analysis of 
RAW cells stimulated with MK1 
EPS. EPS was treated with a poly-
myxin B-affinity column to remove 
the possible contaminants of endo-
toxin. The RAW cells were cultured
in the presence of EPS (100μg/ml) 
for 2 days. The cells were collected, 
washed and used for immuno-
phenotypic analysis. The levels of 
expression (thin line) are shown 
along with the isotype control 
(shaded line).
Figure 6. Cytokine and nitric oxide production of RAW cells 
stimulated with MK1 EPS. EPS was treated with a polymyxin B-affinity 
column to remove any possible endotoxin contamination. The RAW 
cells were cultured in the presence of different MK1 EPS 
concentrations (0.8, 4, 20 and 100μg/ml) for 2 days, and the culture 
supernatants were assayed for TNF-α (A), IL-1β (B). The amounts 
of nitric oxide were measured using a Griess reagent (C).
ing FITC. The cells were incubated for 2 hr and washed with 
pre-warmed  PBS  to  remove  the  unphagocytozed  micro-
spheres.  The  cells  were  harvested,  fixed  and  analyzed  by 
flow cytometry. As shown in Fig. 7, the thin line histograms 
represent the phagocytic activity of RAW cells stimulated with 
EPS, and the shaded histograms represent the phagocytic ac-
tivity  of  the  untreated  RAW  cells.  EPS  activated  the  phag-
ocytic activity. This demonstrates that EPS is an activator of Immunomodulatory Activity of Exopolysaccharide
Sun-A Im, et al.
236 IMMUNE NETWORK http://www.ksimm.or.kr Volume 10 Number 6 December 2010
Figure 7. Phagocytic activity of RAW cells stimulated with MK1 EPS. EPS was treated with a polymyxin B-affinity column to remove any possible
endotoxin contamination. The RAW cells were cultured in the presence of EPS (100μg/ml) for 2 days, followed by the addition of microspheres
containing fluorescein isothiocyanate (FITC). After 2 hr, unphagocytozed microspheres were removed by washing. The cells were harvested, fixed,
and analyzed by flow cytometry. The thin line histograms represent the phagocytic activity of the RAW cells stimulated with MK1 EPS and 
the shaded histograms represent the phagocytic activity of the untreated RAW cells.
macrophages. Passage of the EPS solution (200μg/ml) with 
the  polymyxin  B-affinity  column  did  not  reduce  the  phag-
ocytic  activity  of  RAW  cells.
DISCUSSION
These results show that the EPS produced by the MK1 strain 
isolated from Neungee mushroom is an immunomodulatory 
polysaccharide with no cytotoxic effects. EPS was shown to 
inhibit the proliferation of RAW cells, inducing morphological 
changes from slightly adherent monocytic cells to strongly ad-
herent  macrophages.  Because  macrophages  are  end  stage 
cells that do not proliferate further, the growth inhibitory ac-
tivity of EPS may be due to the induction of further differ-
entiation  of  monocytic  RAW  cells.  EPS  was  also  shown  to 
stimulate RAW cells to produce nitric oxide, which is the prin-
cipal  effecter  molecule  produced  by  macrophages  for  cyto-
toxic activity and can be used as a quantitative index of mac-
rophage activation (34). EPS stimulated the RAW cells to pro-
duce TNF-α and IL-1β, which have often been implicated 
as key mediators produced from macrophages in response to 
bacterial  LPS,  infection  and  inflammatory  stimuli  (35,36).
    Immature macrophages do not induce primary immune re-
sponses  because  they  do  not  express  the  requisite  class  II 
MHC  molecules  and  co-stimulatory  molecules,  nor  do  they 
express  antigenic  peptides  as  stable  complexes  with  MHC 
molecules.  EPS  was  shown  to  enhance  the  expression  of 
co-stimulatory molecules, such as B7-1 and B7-2, and class 
II MHC molecules. One of the most important parameters of 
macrophage  activation  is  the  increased  phagocytic  activity. 
Phagocytosis  is  an  innate  immune  response  mechanism  for 
the removal of foreign pathogens. EPS was shown to activate 
the phagocytic activity on macrophages. These results show 
t h a t  E P S  i s  a  g o o d  a c t i v a t o r  o f  m a c r o p h a g e s .
    Indeed,  plant-derived  polysaccharides  have  been  im-
plicated  for  immunostimulatory  polysaccharides.  For  exam-
ple,  immunostimulatory  polysaccharides  have  been  isolated 
from Aloe vera (32,37), Angelica acutiloba (38), Coriolus ver-
siclor (39), Schizophyllum commune (40), and Lentinus ed-
odes  (41).  The  immunostimulatory  polysaccharides  isolated 
from  these  plants  or  mushrooms  appear  to  trigger  the  im-
m u n e  r e s p o n s e s  p r i m a r i l y  b y  a ctivating  macrophages,  even 
though the direct activation of B cells and other immune cells 
has  been  implicated.  Composition  analysis  of  the  poly-
saccharide suggests that it is quite different from well known 
immunomodulatory polysaccharides, such as acemannan, len-
tinan and PSK (37,39,41). Possible contamination of endotox-
in is always a concern for high molecular weight components 
because endotoxin is a strong activator of macrophages and 
is  contaminated  in  many  plant  materials.  In  this  study,  the 
macrophage-activating activity of EPS was not due to endo-
toxin  contamination,  as  shown  by  polymyxin  B-treatment 
experiments. A particular component of microbial EPS seems 
to  be  engaged  in  specific  bioactivity.  For  example,  phos-
phate-containing  EPS  produced  by  Lactobacillus  delbrueckii 
sp. bulgaricus induced macrophage activation (42). Mannose- 
rich  EPS  from  Tremella  mesenterica  (43)  or  rhamnose-rich 
(6-deoxy-L-mannose) EPS from Lactobacillus rhamnosus (44) Immunomodulatory Activity of Exopolysaccharide
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stimulated the immune system through the mannose receptors 
situated  on  macrophage.  Fucosamine-containing  EPS  pro-
duced  by  a  marine  Pseudomonas e x h i b i t e d  s t r o n g  a n t i v i r a l  
activity (11). L-fucose-enriched EPS would be used as a skin 
moisturizing agent in the cosmetic industry because L-fucose 
exhibited  anticancer  and  anti-inflammatory  activity  (45). 
Sulfate-containing EPS showed a broad range of important bi-
oactivities,  such  as  antioxidant,  anticoagulant,  and  antith-
rombotic activities (46). Therefore, it is possible that macro-
phage activation by EPS would be associated with the rham-
nose  or  mannose  moieties  in  its  structure.
  Macrophages are the most important defense cells in the 
i m m u n e  s y s t e m  i n  t h a t  t h e y  n o t  o n l y  i n i t i a t e  i m m u n e  r e -
s p o n s e s ,  b u t  c a n  a l s o  s e r v e  a s  e f f e c t e r  c e l l s .  F u r t h e r m o r e ,  
macrophages are unique components of the innate immunity 
and  have  a  range  of  functions  related  to  the  activation 
process. Activated macrophages become more efficient anti-
gen presenting cells because they express increased levels of 
class II MHC molecules and co-stimulatory molecules (47), al-
tered  phagocytic  activity  as  well  as  increased  cytokine  and 
nitric oxide production (48). Because EPS exerts strong mac-
rophage-activating activity and the MK1 strain produces copi-
ous amounts of EPS, these results may lead to the discovery 
of a new source of immunomodulatory polysaccharides that 
can  be  obtained  in  large  quantities.
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